
Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company. Cambridge biotech Alchemab Therapeutics has extended...
Cambridge biotech Alchemab has extended its Series A with a £25m British Business Bank investment, the lender’s largest in a life sciences company. Cambridge biotech Alchemab Therapeutics has extended...